Previous 10 |
Armata Pharmaceuticals (NYSEMKT: ARMP ) is granted two patents by the European Patent Office and one by the Canadian Intellectual Property Office covering various aspects of it's bacteriophage program, and AP-SA01, which is in development against various diseases or indications caused by S...
MARINA DEL REY, Calif. , June 3, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company continues to...
Gainers: Soliton (NASDAQ: SOLY ) +124% . Exela Technologies (NASDAQ: XELA ) +33% . Flexible Solutions International (NYSEMKT: FSI ) +24% . IMAC Holdings (NASDAQ: IMAC ) +20% . Biocept (NASDAQ: BIOC ) +21% . Anaplan (NYSE: PLAN ) +18% . MYnd Analytics (NASDAQ: MYND ) +18% . Sea...
Armata Pharmaceuticals (NYSEMKT: ARMP ) +28% on encouraging AP-PA01 data . More news on: Armata Pharmaceuticals, Inc., Biocept, Inc., The9 Limited, Stocks on the move, Read more ...
MARINA DEL REY, Calif , May 28, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced the publication of a case stud...
News, Short Squeeze, Breakout and More Instantly...
Armata Pharmaceuticals Inc. Company Name:
ARMP Stock Symbol:
NYSE Market:
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology com...
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva PR Newswire Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES , March 4, 20...
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit PR Newswire LOS ANGELES , Feb. 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on...